IFNG and breast adenocarcinoma: Interestingly, one out of the six mammary adenocarcinoma cell lines (FMCp, Fig 4c) did not express PD-L1 even after IFN-γ stimulation, suggesting a defect in the expression machinery of PD-L1 or IFN-γ signaling pathway.